查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2151871

美國壓瘡治療市場規模、佔有率和趨勢分析報告：按產品、臨床嚴重程度、最終用途和細分市場預測（2026-2033 年）

U.S. Pressure Ulcer Treatment Market Size, Share & Trends Analysis Report By Product, By Clinical Severity, By End Use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 170 Pages | 商品交期: 2-10個工作天內

價格

美國壓瘡治療市場概述

預計到 2025 年，美國壓瘡治療市場價值將達到 23 億美元，到 2026 年將成長至 24 億美元，到 2033 年將擴大至 34 億美元，2026 年至 2033 年的複合年成長率為 5.4%。

美國壓瘡治療市場的成長是由以下因素推動的：住院和長期照護患者持續遭受壓瘡困擾；人們越來越關注壓瘡預防和治療效果的品質；先進的創傷護理技術得到更廣泛的應用；以及醫院、療養院和居家醫療機構對專業治療的需求不斷成長。

持續存在的壓瘡負擔推動了美國醫療保健領域對有效創傷護理和治療方案的需求。例如，根據美國醫療保健研究與品質署 (AHRQ) 病患安全資料庫網路圖表，截至 2024 年 12 月，共報告了 93,807 例壓瘡事件。在 17,077 例可獲得最嚴重階段有效資訊的事件中，66.6% (11,377 例) 為深部組織潰瘍，10.2% (1,748 例) 為 3 期潰瘍，約 21.1% (3,600 例) 無法分類。該報告還指出，在 17,936 例報告病例中，77.1% 的病例發生在接受預防性干預的患者中，這表明儘管採取了預防措施，壓瘡仍然會繼續發生。此外，在通報的病例中，63.8%出現了繼發性併發症或結局不明，其中4期壓瘡的不利事件發生率最高，達82%。大量晚期且可能造成嚴重危害的壓瘡的存在，凸顯了對先進敷料、負壓傷口治療、壓瘡減少系統和其他治療方案的持續高需求。

臨床試驗趨勢

臨床試驗正透過為治療嚴重且難癒合傷口的先進生物療法提供臨床證據，推動美國壓瘡治療市場的創新。研究重點在於細胞、非細胞和基質樣產品，這些產品能夠加速傷口癒合，並改善難癒合的III期和IV期壓瘡患者的預後。例如，2025年5月，Tiger Biosciences, LLC在美國啟動了一項IV期臨床試驗（NCT06999590），旨在評估多種細胞、非細胞和基質樣產品（CAMPs），包括ACApatch和caregraFT，與標準創傷護理聯合用於治療難癒合壓瘡的療效。這項多中心、前瞻性、隨機對照試驗（改良平台試驗）預計將招募約500名患有慢性III期或IV期壓瘡的成年患者。本研究將比較每週接受一次生物製藥合併標準治療的患者組與僅接受配對標準治療的對照組，以傷口完全癒合為主要終點。該研究預計將於2027年5月完成。這項研究凸顯了先進的生物和再生醫學創傷護理療法的加速發展，並有望加強臨床證據，支持在美國壓力性潰瘍治療市場採用活性生物療法，特別是細胞、無細胞和基質類產品。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：美國壓瘡治療市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • 美國壓力性潰瘍治療市場分析工具

第4章：美國壓力性潰瘍治療市場：產品特定估算與趨勢分析

  • 美國壓力性潰瘍治療市場：基於產品的趨勢分析，2025 年和 2033 年
  • 美國壓力性潰瘍治療市場：基於產品的規模和趨勢分析，2021-2033年
  • 創傷護理敷料
    • 潮濕
    • 抗菌劑
  • 主動療法和生物療法
    • 活性生物材料
    • 生物醫學皮膚替代品
    • 生長因子
  • 創傷護理設備和系統
    • 負壓傷口治療（NPWT）
    • 壓力分佈和支撐面
    • 高壓氧氣治療裝置
    • 電刺激設備
  • 外用製劑及藥理製劑
    • 傷口清潔劑
    • 局部抗菌劑和消毒劑
  • 其他治療產品
    • 減輕負荷和保持姿勢的裝置
    • 傷口清潔和沖洗產品

第5章：美國壓瘡治療市場：依臨床嚴重程度分類的估算與趨勢分析

  • 美國壓瘡治療市場：以臨床嚴重程度分類的波動分析（2025 年和 2033 年）
  • 從 2021 年到 2033 年，以臨床嚴重程度分析美國壓瘡治療市場的規模和趨勢。
  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段
  • 深部組織損傷（DTI）

第6章：美國壓力性潰瘍治療市場：依最終用途分類的估算與趨勢分析

  • 美國壓力性潰瘍治療市場：按最終用途分類的趨勢分析（2025 年和 2033 年）
  • 美國壓力性潰瘍治療市場：依最終用途分類的規模和趨勢分析（2021-2033年）
  • 急診醫院
  • 長期急性護理醫院
  • 燒燙傷治療中心
  • 門診手術中心
  • 醫院門診部創傷護理診所
  • 住院復健機構
  • 護理機構
  • 長期照護（居住環境）
  • 診所
  • 家庭醫療保健

第7章 競爭情勢

  • 主要市場參與企業的最新趨勢及影響分析
  • 公司分類
  • 企業市場占有率分析，2025 年
  • 企業熱力圖分析
  • 策略規劃
    • 業務拓展
    • 併購
    • 夥伴關係與合作
    • 新技術的引入
    • 研究與開發
    • 公司簡介
    • SYST'AM
    • Ulcer Solutions, LLC.
    • 前鋒
    • 巴克斯特（希爾羅姆）
    • Arjo
    • LINET
    • Invacarea 公司
    • 3M
    • Smith+Nephew
    • Molnlycke AB
    • 薩瓦里亞
    • 約恩斯醫療保健
    • B. Braun SE
    • Medline
    • 康維特
Product Code: GVR-4-68041-039-8

U.S. Pressure Ulcer Treatment Market Summary

The U.S. pressure ulcer treatment market size was valued at USD 2.3 billion in 2025 and is projected to grow from USD 2.4 billion in 2026 to USD 3.4 billion by 2033, at a CAGR of 5.4% from 2026 to 2033. The growth of the U.S. pressure ulcer treatment market is driven by the persistent burden of pressure injuries among hospitalized and long-term-care patients, increasing focus on pressure injury prevention and quality outcomes, rising adoption of advanced wound-care technologies, and growing demand for specialized treatment across hospitals, skilled nursing facilities, and home healthcare settings.

The continuing burden of pressure injuries is increasing demand for effective wound-care and treatment solutions across U.S. healthcare settings. For instance, AHRQ Network of Patient Safety Databases Chartbook, 93,807 pressure injury events were reported through December 2024. Among the 17,077 events with valid information on the most advanced stage, 66.6% (11,377 cases) were deep tissue pressure injuries, 10.2% (1,748 cases) were Stage 3, and approximately 21.1% (3,600 cases) were unstageable. The report also found that 77.1% of 17,936 reported events involved patients who had received a preventive intervention, indicating that pressure injuries continue to occur despite preventive measures. Furthermore, 63.8% of reported cases developed a secondary morbidity or had an unknown outcome, while Stage 4 injuries showed the highest reported harm rate at 82%. The substantial number of advanced and potentially harmful pressure injuries supports continued demand for advanced dressings, negative pressure wound therapy, pressure-relieving systems, and other treatment solutions.

Clinical Trials Landscape

Clinical trials are supporting innovation in the U.S. pressure ulcer treatment market by generating clinical evidence on advanced biological therapies for severe and nonhealing wounds. Research is focused on cellular, acellular, and matrix-like products that can accelerate wound closure and improve outcomes in patients with difficult-to-heal Stage III and Stage IV pressure ulcers. For instance, in May 2025, Tiger Biosciences, LLC initiated the Phase 4 NCT06999590 clinical trial in the U.S. to evaluate several cellular, acellular, and matrix-like products (CAMPs), including ACApatch and caregraFT, in combination with standard wound care for nonhealing pressure ulcers. The multicenter, prospective, randomized controlled modified platform trial plans to enroll approximately 500 adult patients with chronic Stage III or Stage IV pressure ulcers. The study will compare weekly applications of these biological products plus standard care with matched standard-of-care controls, with complete wound closure serving as the primary outcome. The trial is expected to be completed in May 2027. The study highlights the growing development of advanced biological and regenerative wound-care therapies and is expected to strengthen clinical evidence supporting the adoption of active & bio-therapies, particularly cellular, acellular, and matrix-based products, in the U.S. pressure ulcer treatment market.

U.S. Pressure Ulcer Treatment Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. pressure ulcer treatment market report based on product, clinical severity, and end use:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Wound Care Dressings
    • Moist
    • Foam Dressings
    • Hydrocolloid Dressings
    • Film Dressings
    • Alginate Dressings
    • Hydrogel Dressings
    • Collagen Dressings
    • Other Advanced Dressing
    • Antimicrobials
    • Silver
    • Non-silver
  • Active & Bio-Therapies
    • Active Biomaterials
    • Bioengineered Skin Substitutes
    • Growth Factors
  • Wound Care Devices & Systems
    • Negative Pressure Wound Therapy (NPWT)
    • Pressure Redistribution & Support Surfaces
    • Hyperbaric Oxygen Equipment
    • Electrical Stimulation Devices
  • Topical & Pharmacological Agents
    • Debriding Agents
    • Topical Antimicrobials & Antiseptics
  • Other Treatment Products
    • Offloading & Positioning Devices
    • Wound Cleansing & Irrigation Products
  • Clinical Severity Outlook (Revenue, USD Million, 2021 - 2033)
  • Stage I
  • Stage II
  • Stage III
  • Stage IV
  • Deep Tissue Injury (DTI)
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Acute Care Hospital
  • Long-term Acute Care Hospital
  • Burn Center
  • Ambulatory Surgery Center
  • Hospital Outpatient Department Wound Care Clinic
  • Inpatient Rehabilitation Facility
  • Skilled Nursing Facility
  • Long-term Care (living setting)
  • Physician Office
  • Home Healthcare

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in U.S.
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Pressure Ulcer Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising pressure-injury burden among aging and high-risk patients
      • 3.2.1.2. Growing hospital focus on pressure-ulcer prevention and quality outcomes
      • 3.2.1.3. Increasing use of advanced wound-care products
      • 3.2.1.4. Rising demand for chronic and complex wound treatment
      • 3.2.1.5. Expansion of evidence-based wound-care protocols
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Improved prevention reducing treatment demand
      • 3.2.2.2. Limited evidence for some advanced therapies
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Expansion of home-based wound care
      • 3.2.3.2. AI-enabled early detection and risk prediction
      • 3.2.3.3. Growth of portable and disposable NPWT
      • 3.2.3.4. Digital wound monitoring and smart sensors
      • 3.2.3.5. Increasing value-based wound-care models
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Variability in wound staging and documentation
      • 3.2.4.2. Need to demonstrate clinical and cost effectiveness
  • 3.3. U.S. Pressure Ulcer Treatment Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. U.S. Pressure Ulcer Treatment Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Pressure Ulcer Treatment Market: Product Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. U.S. Pressure Ulcer Treatment Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 4.4. Wound Care Dressings
    • 4.4.1. Wound care dressings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Moist
      • 4.4.2.1. Moist market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.2. Foam Dressings
        • 4.4.2.2.1. Foam dressings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.3. Hydrocolloid Dressings
        • 4.4.2.3.1. Hydrocolloid dressings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.4. Film Dressings
        • 4.4.2.4.1. Film dressings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.5. Alginate Dressings
        • 4.4.2.5.1. Alginate dressings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.6. Hydrogel Dressings
        • 4.4.2.6.1. Hydrogel dressings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.7. Collagen Dressings
        • 4.4.2.7.1. Collagen dressings market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.2.8. Other Advanced Dressing
        • 4.4.2.8.1. Other advanced dressing market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Antimicrobials
      • 4.4.3.1. Antimicrobials market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.2. Silver
        • 4.4.3.2.1. Silver market revenue estimates and forecasts, 2021 - 2033 (USD Million)
      • 4.4.3.3. Non-silver
        • 4.4.3.3.1. Non-silver market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Active & Bio-Therapies
    • 4.5.1. Active & bio-therapies market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Active Biomaterials
      • 4.5.2.1. Active biomaterials market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Bioengineered Skin Substitutes
      • 4.5.3.1. Bioengineered skin substitutes market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Growth Factors
      • 4.5.4.1. Growth factors market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Wound Care Devices & Systems
    • 4.6.1. Wound care devices & systems market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.2. Negative Pressure Wound Therapy (NPWT)
      • 4.6.2.1. Negative pressure wound therapy (NPWT) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.3. Pressure Redistribution & Support Surfaces
      • 4.6.3.1. Pressure redistribution & support surfaces market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.4. Hyperbaric Oxygen Equipment
      • 4.6.4.1. Hyperbaric oxygen equipment market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.6.5. Electrical Stimulation Devices
      • 4.6.5.1. Electrical stimulation devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Topical & Pharmacological Agents
    • 4.7.1. Topical & pharmacological agents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. Debriding Agents
      • 4.7.2.1. Debriding agents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.3. Topical Antimicrobials & Antiseptics
      • 4.7.3.1. Topical antimicrobials & antiseptics market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. Other Treatment Products
    • 4.8.1. Other treatment products market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.2. Offloading & Positioning Devices
      • 4.8.2.1. Offloading & positioning devices market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.8.3. Wound Cleansing & Irrigation Products
      • 4.8.3.1. Wound cleansing & irrigation products market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Pressure Ulcer Treatment Market: Clinical Severity Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Pressure Ulcer Treatment Market: Clinical Severity Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. U.S. Pressure Ulcer Treatment Market Size & Trend Analysis, by Clinical Severity 2021 to 2033 (USD Million)
  • 5.4. Stage I
    • 5.4.1. Stage I market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.5. Stage II
    • 5.5.1. Stage II market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.6. Stage III
    • 5.6.1. Stage III market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.7. Stage IV
    • 5.7.1. Stage IV market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 5.8. Deep Tissue Injury (DTI)
    • 5.8.1. Deep tissue injury (DTI) market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Pressure Ulcer Treatment Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Pressure Ulcer Treatment Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
  • 6.3. U.S. Pressure Ulcer Treatment Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 6.4. Acute Care Hospital
    • 6.4.1. Acute care hospital market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.5. Long-term Acute Care Hospital
    • 6.5.1. Long-term acute care hospital market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.6. Burn Center
    • 6.6.1. Burn center market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.7. Ambulatory Surgery Center
    • 6.7.1. Ambulatory surgery center market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.8. Hospital Outpatient Department Wound Care Clinic
    • 6.8.1. Hospital outpatient department wound care clinic market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.9. Inpatient Rehabilitation Facility
    • 6.9.1. Inpatient rehabilitation facility market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.10. Skilled Nursing Facility
    • 6.10.1. Skilled nursing facility market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.11. Long-term Care (living setting)
    • 6.11.1. Long-term care (living setting) market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.12. Physician Office
    • 6.12.1. Physician office market revenue estimates and forecasts, 2021 - 2033 (USD Million)
  • 6.13. Home Healthcare
    • 6.13.1. Home healthcare market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Market Share Analysis, 2025
  • 7.4. Company Heat Map Analysis
  • 7.5. Strategy Mapping
    • 7.5.1. Expansion
    • 7.5.2. Mergers & Acquisition
    • 7.5.3. Partnerships & Collaborations
    • 7.5.4. New Technology Launches
    • 7.5.5. Research And Development
    • 7.5.6. Company Profiles
    • 7.5.7. SYST'AM
      • 7.5.7.1. Company overview
      • 7.5.7.2. Financial performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Ulcer Solutions, LLC.
      • 7.5.8.1. Company overview
      • 7.5.8.2. Financial performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Stryker
      • 7.5.9.1. Company overview
      • 7.5.9.2. Financial performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. Baxter (Hillrom)
      • 7.5.10.1. Company overview
      • 7.5.10.2. Financial performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic initiatives
    • 7.5.11. Arjo
      • 7.5.11.1. Company overview
      • 7.5.11.2. Financial performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic initiatives
    • 7.5.12. LINET
      • 7.5.12.1. Company overview
      • 7.5.12.2. Financial performance
      • 7.5.12.3. Product Benchmarking
      • 7.5.12.4. Strategic initiatives
    • 7.5.13. Invacare Corporation
      • 7.5.13.1. Company overview
      • 7.5.13.2. Financial performance
      • 7.5.13.3. Product Benchmarking
      • 7.5.13.4. Strategic initiatives
    • 7.5.14. 3M
      • 7.5.14.1. Company overview
      • 7.5.14.2. Financial performance
      • 7.5.14.3. Product Benchmarking
      • 7.5.14.4. Strategic initiatives
    • 7.5.15. Smith+Nephew
      • 7.5.15.1. Company overview
      • 7.5.15.2. Financial performance
      • 7.5.15.3. Product Benchmarking
      • 7.5.15.4. Strategic initiatives
    • 7.5.16. Molnlycke AB
      • 7.5.16.1. Company overview
      • 7.5.16.2. Financial performance
      • 7.5.16.3. Product Benchmarking
      • 7.5.16.4. Strategic initiatives
    • 7.5.17. Savaria
      • 7.5.17.1. Company overview
      • 7.5.17.2. Financial performance
      • 7.5.17.3. Product Benchmarking
      • 7.5.17.4. Strategic initiatives
    • 7.5.18. Joerns Healthcare
      • 7.5.18.1. Company overview
      • 7.5.18.2. Financial performance
      • 7.5.18.3. Product Benchmarking
      • 7.5.18.4. Strategic initiatives
    • 7.5.19. B. Braun SE
      • 7.5.19.1. Company overview
      • 7.5.19.2. Financial performance
      • 7.5.19.3. Product Benchmarking
      • 7.5.19.4. Strategic initiatives
    • 7.5.20. Medline
      • 7.5.20.1. Company overview
      • 7.5.20.2. Financial performance
      • 7.5.20.3. Product Benchmarking
      • 7.5.20.4. Strategic initiatives
    • 7.5.21. Convatec
      • 7.5.21.1. Company overview
      • 7.5.21.2. Financial performance
      • 7.5.21.3. Product Benchmarking
      • 7.5.21.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 U.S. pressure ulcer treatment market, by product, 2021 - 2033 (USD Million)
  • Table 3 U.S. pressure ulcer treatment market, by clinical severity, 2021 - 2033 (USD Million)
  • Table 4 U.S. pressure ulcer treatment market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. pressure ulcer treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 U.S. pressure ulcer treatment market size and growth prospects (USD Million)
  • Fig. 11 U.S. pressure ulcer treatment market: Industry Value Chain Analysis
  • Fig. 12 U.S. pressure ulcer treatment market: Market Dynamics
  • Fig. 13 U.S. pressure ulcer treatment market: PORTER's Analysis
  • Fig. 14 U.S. pressure ulcer treatment market: PESTEL Analysis
  • Fig. 15 U.S. pressure ulcer treatment market share by product, 2025 & 2033 (USD Million)
  • Fig. 16 U.S. pressure ulcer treatment market, by product: market share, 2025 & 2033
  • Fig. 17 Wound care dressings market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 18 Moist market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 19 Foam dressings market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 Hydrocolloid dressings market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 Film dressings market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Alginate dressings market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Hydrogel dressings market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Collagen dressings market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Other advanced dressing market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Antimicrobials market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Silver market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Non-silver market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Active & bio-therapies market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Active biomaterials market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Bioengineered skin substitutes market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Growth factors market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Wound care devices & systems market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Negative pressure wound therapy (NPWT) market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Pressure redistribution & support surfaces market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Hyperbaric oxygen equipment market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Electrical stimulation devices market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Topical & pharmacological agents market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Debriding agents market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Topical antimicrobials & antiseptics market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Other treatment products market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Offloading & positioning devices market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Wound cleansing & irrigation products market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 U.S. pressure ulcer treatment market share by clinical severity, 2025 & 2033 (USD Million)
  • Fig. 45 U.S. pressure ulcer treatment market, by clinical severity: market share, 2025 & 2033
  • Fig. 46 Stage I market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Stage II market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Stage III market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Stage IV market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Deep tissue injury (DTI) market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 U.S. pressure ulcer treatment market share by end use, 2025 & 2033 (USD Million)
  • Fig. 52 U.S. pressure ulcer treatment market, by end use: market share, 2025 & 2033
  • Fig. 53 Acute care hospital market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Long-term acute care hospital market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Burn center market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Ambulatory surgery center market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Hospital outpatient department wound care clinic market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Inpatient rehabilitation facility market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Skilled nursing facility market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Long-term care (living setting) market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Physician office market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Home healthcare market estimates & forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key company categorization
  • Fig. 64 Company market positioning
  • Fig. 65 Key company market share analysis, 2025
  • Fig. 66 Strategic framework